- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 9 - Sodium Glucose Cotransporter 2 Inhibitors and Type 2 Diabetes Mellitus
During this segment, Peter Salgo, MD, leads a discussion about the use of sodium glucose cotransporter 2 (SGLT-2) inhibitors for the treatment of type 2 diabetes mellitus (T2DM). Dr Salgo describes the mechanism of action of SGLT-2 inhibitors and highlights efficacy data for 2 agents approved by the FDA: canagliflozin and dapagliflozin.
Dr Salgo adds that because SGLT-2 inhibitors have been associated with weight loss, they are attractive to patients. However, Yehuda Handelsman, MD, FACP, FACE, FNLA, notes that SGLT-2 inhibitors may not be effective in patients with impaired renal function.
Maria Lopes, MD, MS, states that clinically meaningful weight loss can have an impact on weight-related comorbidities and can enable patients to reach blood pressure goals. Dr Lopes explains that reaching multiple goals, such as weight loss and blood pressure goals, is important in terms of reducing a patient’s risk for cardiovascular disease.
Kari Uusinarkaus, MD, FAAFP, FNLA, further discusses risks that physicians must consider when treating their patients with SGLT-2 inhibitors.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More
